Calidi Biotherapeutics, Inc. (CLDWW) — DEF 14A Filings
All DEF 14A filings from Calidi Biotherapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Calidi Biotherapeutics Sets Virtual Annual Meeting, Proposes Reverse Split
— May 23, 2025 Risk: high
Calidi Biotherapeutics, Inc. (CLDWW) has filed a DEF 14A proxy statement for its virtual Annual Meeting on July 9, 2025, at 9:30 a.m. Pacific Time. Key proposal -
Calidi Biotherapeutics Announces Special Meeting of Stockholders on June 6, 2024
— May 9, 2024 Risk: medium
Calidi Biotherapeutics, Inc. (CLDWW) filed a Proxy Statement (DEF 14A) with the SEC on May 9, 2024. Calidi Biotherapeutics, Inc. will hold a virtual Special Mee
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX